News Release

Inequities in cancer treatment delay or discontinuation following SARS-CoV-2 infection

JAMA Network Open

Peer-Reviewed Publication

JAMA Network

About The Study: The findings of this study of 4,768 patients with cancer suggest that race and ethnicity and area-level social determinants of health were associated with delayed or discontinued cancer treatment and longer delays to the restart of drug-based therapies following SARS-CoV-2 infection. Such treatment delays could exacerbate persistent cancer survival inequities in the United States. 

Authors: Adana A. M. Llanos, Ph.D., M.P.H., of the Columbia University Irving Medical Center in New York, is the corresponding author. 

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamanetworkopen.2022.51165)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.51165?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=011323

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.